{"id":"W4408099258","doi":"10.1182/bloodadvances.2024015086","title":"Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University Health Network","funders":"","keywords":"Nivolumab; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000124783,0.0002046046,0.0003852962,0.0001670313,0.0001085023,0.00002072847,0.0001066745,0.00009883993,0.00002862504],"category_scores_gemma":[0.00009854103,0.0001406549,0.00008530675,0.0005500953,0.0001301252,0.0002279129,0.00002390977,0.0001578889,0.000002167521],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001126635,"about_ca_system_score_gemma":0.0003173559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002147378,"about_ca_topic_score_gemma":0.0001710998,"domain_scores_codex":[0.9987154,0.00003380991,0.0003356632,0.0003721816,0.000218242,0.0003247096],"domain_scores_gemma":[0.9992365,0.0001884577,0.000147383,0.0002758643,0.0001100422,0.00004178516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1168305,0.007118469,0.7911881,0.002888304,0.0007085412,0.0001276605,0.001721292,0.00004458536,0.004114202,0.0005741817,0.002094811,0.07258943],"study_design_scores_gemma":[0.2591847,0.01727511,0.2816879,0.00631538,0.001148352,0.00002516967,0.001921467,0.0001824754,0.02967997,0.0009136504,0.4003336,0.001332168],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9788196,0.01334034,0.0001712908,0.000719821,0.0002868865,0.00249134,0.0000376197,0.0001133292,0.004019788],"genre_scores_gemma":[0.980077,0.0005112872,0.006641813,0.0003597448,0.00003586076,0.0004521019,0.00005744267,0.00003505915,0.01182964],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5095002,"threshold_uncertainty_score":0.5735741,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007325588110520284,"score_gpt":0.2586844360969415,"score_spread":0.2513588479864212,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}